News
Researchers at the Pennington Biomedical Research Center conducted a first-of-its-kind study to provide insights into the ...
Eli Lilly and Company's orforglipron had good results in Type 2 diabetes trials, potentially becoming the first scalable oral ...
7h
Woman's World on MSNFridays Weight Loss: Real Facts and Figures About the Online GLP-1 Prescriber With an Exclusive Brand Interview!Fridays weight loss is a telehealth provider that offers access to popular GLP-1 medications, including compounded versions ...
Researchers at the Pennington Biomedical Research Center have found new clues about how the drug tirzepatide, also known by ...
5d
Pharmaceutical Technology on MSNEli Lilly sues Mochi Health and others for ‘deceptive’ tirzepatide marketingMochi Health, one of those implicated, is one of the largest telehealth providers of compounded GLP-1RAs. Eli Lilly maintains ...
Jaime Almandoz, MD, MBA, of UT Southwestern Medical Center, speaks on results of a study that investigated tirzepatide uptake ...
A judge denied compounders' request to keep making off-brand Wegovy and Ozempic after the FDA removed semaglutide from its shortage list.
In December 2024, the FDA affirmed that the shortage of tirzepatide, marketed as Zepbound for weight loss, had ended, ...
Tirzepatide linked to more GI issues than semaglutide in new study on weight-loss drugs without diabetes. Read more!
All these drugs are very effective and they’ve become a game changer for people who need to lose weight. Get on the drug, eat ...
Slimjaro Emerges as the Leading Natural Mounjaro Recipe for Weight Loss in 2025—Delivering a Powerful OTC Tirzepatide ...
Service GLP-1 Medication Platform Offering Affordable Access to Semaglutide, Tirzepatide, and Phentermine with 24/7 Coaching, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results